UK Has More Than Enough COVID-19 Vaccines For People Under 30 - Health Minister
Fahad Shabbir (@FahadShabbir) Published April 08, 2021 | 02:50 PM
UK Health Minister Matt Hancock said on Thursday that the government has secured "more than enough" COVID-19 vaccine supplies to offer all adults under 30 a vaccine other than AstraZeneca's, whose application has not been recommended for this age sector over concerns that it may cause rare blood clots in younger people
LONDON (UrduPoint News / Sputnik - 08th April, 2021) UK Health Minister Matt Hancock said on Thursday that the government has secured "more than enough" COVID-19 vaccine supplies to offer all adults under 30 a vaccine other than AstraZeneca's, whose application has not been recommended for this age sector over concerns that it may cause rare blood clots in younger people.
"There are 10.16 million people aged 18-29 in the UK, 1.6 million of them have already had their first jab ... and we have more than enough Pfizer and Moderna vaccine to cover all of the remaining 8.5 million people aged between 18-29 if necessary," Hancock told the Sky news broadcaster.
According to the health secretary, the UK has 40 million Pfizer vaccines in production and another 17 million doses of the Moderna jabs coming through.
"We've got more than enough jabs and we are on track to hit the target that we've set that we will ensure every adult in UK is offered the jab by the end of July," he stressed.
On Wednesday, the UK government's Joint Committee on Vaccination and Immunization recommended that people under 30 be offered an alternative to AstraZeneca amid concerns that the anti-coronavirus vaccine may cause rare blood clots in younger people.
The Medicines and Healthcare products Regulatory Agency, which in January approved the application of the drug developed by the UK-Swedish pharmaceutical company and the University of Oxford, said that 51 women and 28 men aged from 18 to 79 developed blood clots after having their first dose in the UK.
The regulator said, however, that these were "very rare side effects" that are still being assessed, and reiterated that the benefits of the AstraZeneca/Oxford vaccine continue to outweigh the risks for most people.
Related Topics
Recent Stories
President calls for further strengthening of Pakistan-UK trade, economic ties
President for better marketing, projection of gemstone industry of Pakistan
26% increase on tobacco tax can reduce PKR 300bn in health cost
China keen to launch uplift projects for Gwadar’s local population: Senator
Pakistan to bring perpetrator of Dasu terrorist attack to justice soon: Lin Jian
Financial crisis at UK's biggest water supplier worsens
French parliament backs bill against hair discrimination affecting black women
Poland raids Russian spy network: security services
Commissioner directs officials to prepare for Shaheed Zaulfiqar Ali Bhutto's ann ..
UK greenhouse gas emissions fell 5.4% in 2023: data
Pakistan's total liquid foreign reserves reach $ 13.42 billion
European stock markets head into Easter break with slight gains
More Stories From Health
-
Increased diagnostic testing for drug resistance
5 days ago -
IRD releases groundbreaking results of end TB programme
7 days ago -
Increased diagnostic testing for drug resistance TB will enhance patients’ treatment outcome
10 days ago -
JRF to provide insulin to underprivileged diabetic patients
12 days ago -
MBBS third professional annual exams 2023: check results here
13 days ago -
CM Maryam visits PIC, inquiries after patients
15 days ago
-
Health expert recommends exercise for weight loss in Ramazan
17 days ago -
Blood camp held at SNGPL office
17 days ago -
Free Medical camp for people with mental, physical disabilities
23 days ago -
Breast cancer has become most common disease in few years: expert
23 days ago -
Punjab Healthcare Commission shuts down 634 illegal treatment centers
23 days ago -
COMSTECH, Al-Shifa Trust team conduct free cataract eye surgeries in Somalia
23 days ago